Pacific Biosciences of Ca...

1.32
-0.24 (-15.38%)
At close: Feb 10, 2025, 3:59 PM
1.34
1.51%
After-hours Feb 10, 2025, 07:58 PM EST
undefined%
Bid 1.34
Market Cap 362.87M
Revenue (ttm) -
Net Income (ttm) -
EPS (ttm) -1.46
PE Ratio (ttm) -0.91
Forward PE n/a
Analyst Buy
Ask 1.35
Volume 21,259,528
Avg. Volume (20D) 9,943,165
Open 1.55
Previous Close 1.56
Day's Range 1.32 - 1.56
52-Week Range 1.16 - 6.83
Beta undefined

About PACB

Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits designed for specific workflow, such as template preparation kit to convert DNA into SMRTbell double-stranded...

Sector Healthcare
IPO Date Oct 27, 2010
Employees 796
Stock Exchange NASDAQ
Ticker Symbol PACB

Analyst Forecast

According to 13 analyst ratings, the average rating for PACB stock is "Buy." The 12-month stock price forecast is $2.5, which is an increase of 88.68% from the latest price.

Buy 53.85%
Hold 46.15%
Sell 0.00%
Stock Forecasts

Next Earnings Release

Pacific Biosciences of California Inc. is scheduled to release its earnings on Feb 13, 2025, after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
2 weeks ago
-8.84%
Pacific Biosciences of California shares are tradi... Unlock content with Pro Subscription
3 weeks ago
-7.96%
Pacific Biosciences shares are trading lower after the company issued worse-than-expected preliminary Q4 revenue.